Subgroup analysis in clinical trials

被引：92

作者：

Cook, DI

Gebski, VJ

Keech, AC

机构：

[1] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia

[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2004年 / 180卷 / 06期

关键词：

D O I：

10.5694/j.1326-5377.2004.tb05928.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：289 / 291

页数：3

共 26 条

[1]

Alderman EL, 1996, NEW ENGL J MED, V335, P217

[2] Statistics Notes - Interaction revisited: the difference between two estimates [J].

Altman, DG ;

Bland, JM .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7382) :219-219

[3] Commentary: Within trial variation - A false trail? [J].

Altman, DG .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (04) :301-303

[4]

[Anonymous], 1988, LANCET, V2, P349

[5] Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].

Assmann, SF ;

Pocock, SJ ;

Enos, LE ;

Kasten, LE .

LANCET, 2000, 355 (9209) :1064-1069

[6]

Brookes S T, 2001, Health Technol Assess, V5, P1

[7]

BURGESS DC, 2002, MED J AUSTRALIA, V179, P1105

[8] Overhauling the breast cancer overview: are subsets subversive? [J].

Coates, AS ;

Goldhirsch, A ;

Gelber, RD .

LANCET ONCOLOGY, 2002, 3 (09) :525-526

[9]

Committee for Proprietary Medicinal Products, 2002, POINTS CONS MULT ISS

[10]

DIJKSTRA BK, 1963, J NATL CANCER I, V31, P511

← 1 2 3 →